1.41
-0.47(-25.00%)
Currency In USD
| Previous Close | 1.88 |
| Open | 1.5 |
| Day High | 1.55 |
| Day Low | 1.38 |
| 52-Week High | 2.75 |
| 52-Week Low | 1.1 |
| Volume | 1.53M |
| Average Volume | 181,159 |
| Market Cap | 10.48M |
| PE | -0.7 |
| EPS | -2 |
| Moving Average 50 Days | 1.67 |
| Moving Average 200 Days | 1.64 |
| Change | -0.47 |
If you invested $1000 in Intelligent Bio Solutions Inc. (INBS) since IPO date, it would be worth $0.53 as of September 17, 2025 at a share price of $1.41. Whereas If you bought $1000 worth of Intelligent Bio Solutions Inc. (INBS) shares 3 years ago, it would be worth $13.05 as of September 17, 2025 at a share price of $1.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System
GlobeNewswire Inc.
8 hours ago
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today provided an update on its FDA 51
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
GlobeNewswire Inc.
Aug 19, 2025 12:30 PM GMT
Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growthNEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025
GlobeNewswire Inc.
Aug 12, 2025 12:30 PM GMT
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announced that its